ESCRS - PP24.11 - Patient-Reported Visual Outcomes Following Cataract Surgery With Rayone Galaxy And Rayone Emv Intraocular Lenses

Patient-Reported Visual Outcomes Following Cataract Surgery With Rayone Galaxy And Rayone Emv Intraocular Lenses

Published 2026 - 44th Congress of the ESCRS

Reference: PP24.11 | Type: Free paper | DOI: 10.82333/d4zb-3775

Authors: Ms Selin Dogramaci* 1 , Prof. Mahmut Dogramaci 2 , Ms Kendall Johnston 3 , Mr Tom Critchley 4 , Mr Alexander Silvester 5 , Mr Stephen Mcatamney 5

1Medical School,University of Buckingham ,Buckingham,United Kingdom, 2Ophthalmology,Spamedica,Chelmsford,United Kingdom, 3Ophthalmology,Freedom Vision,Colchester,United Kingdom, 4Ophthalmology,Spamedica,Manchester,United Kingdom, 5Ophthalmology,Spamedica,Bolton,United Kingdom

Purpose

To evaluate patient-reported visual outcomes following cataract surgery with RayOne Galaxy and RayOne EMV intraocular lenses using a structured postoperative patient feedback questionnaire.

Setting

Freedom Vision  and Spamedica hospitals, UK

Methods

Patient-reported outcomes were collected using the RayPRO postoperative questionnaire distributed to patients undergoing cataract surgery with Rayner intraocular lenses. The questionnaire evaluates satisfaction with surgical outcomes, spectacle independence for distance, intermediate and near activities, and visual disturbances such as glare, halos and starbursts.

A total of 4877 eyes implanted with RayOne Galaxy (n = 2354) and RayOne EMV (n = 2523) intraocular lenses were included in the clinical dataset. Patient feedback responses were analysed for patients completing the questionnaire. As not all patients responded, analysis was performed using completed responses only.

 

Results

A total of 1752 patient responses were analysed, including 1315 responses from patients with RayOne EMV and 437 responses from patients with RayOne Galaxy. Overall satisfaction was 83% for RayOne EMV and 84% for RayOne Galaxy groups. Patients implanted with RayOne Galaxy reported higher overall spectacle independence (92%) compared with RayOne EMV (71%). Distance spectacle independence was reported by 94% of RayOne Galaxy patients and 83% of RayOne EMV patients. Intermediate spectacle independence was reported by 93% and 75%, respectively, while near spectacle independence was reported by 91% and 54%, respectively. Patient-reported dysphotopsia symptoms were reported in 30% of RayOne Galaxy patients and 28% of RayOne EMV patients.

Conclusions

In this large real-world cohort of cataract surgery patients, high levels of postoperative satisfaction were reported following implantation of RayOne intraocular lenses. RayOne Galaxy lenses were associated with higher levels of spectacle independence across distance, intermediate and near visual tasks compared with RayOne EMV lenses, while overall satisfaction and dysphotopsia rates were similar between groups. These findings highlight the value of incorporating patient-reported outcomes alongside clinical measures when evaluating intraocular lens performance.